The companies will develop high performance integrated solutions to study human electromagnetic brain activity using MEG and EEG for research and clinical diagnostics.
MEG and EEG are non-invasive measurement techniques that can explain neuronal activities human cortex with great temporal and spatial detail.
The combination also plays an important role in presurgical evaluation of epilepsy patients. It is also used to study other neurodegenerative disorders, like Alzheimer's.
According to York Instruments, the partnership will enable it to offer its users with high resolution EEG measurements and clinical analysis software, which complements its MEG solutions.
York Instruments' president James R Petite said: "The collaboration with eemagine GmbH is an important milestone toward the upcoming release of York Instruments' MEGSCAN complete package solution."
He said: "We are convinced this cooperation will benefit both parties in their efforts to accelerate the development of new and exciting MEG applications that meet even the most advanced requirements in neuroscience and clinical use.“
eemagine CEO Frank Zanow said: "We are delighted to enter into this agreement with a focused and ambitious partner in the MEG industry.
"Our company has a long history in MEG analysis software and vast expertise using EEG data with our ASA software and eego EEG amplifier line, as brought to the market by ANT Neuro, a leading supplier in neuroscience."
York Instruments is a UK-based company that specialises in magnetic measurements and their applications in healthcare.
Established in 1999, Eemagine is Germany-based company that claims to specialise in products related to neuroscience, neurodiagnostics and neuromodulation.
